Leaders Magazine—July 3, 2017
Leaders Magazine interviewed Lionel B. Ivashkiv, MD, chief scientific officer at HSS, about his role in developing scientific programs and research.
"As the CSO, I oversee the entire spectrum of clinical, translational, and basic research. One of my jobs is to integrate those so we can identify the most important problems in the clinic, work on them at the bench, and bring back any discoveries and findings to our patients," he said.
According to Dr. Ivashkiv, a great strength of HSS is the combination of excellence in the clinical and research areas.
"We’re also one of the few in the world that is solely focused on musculoskeletal conditions in orthopedics and rheumatology. That allows us to leverage the power of numbers and resources. This is not just because of our resources in science, but also our access to large populations of patients that we can study," he added.
Additionally, Dr. Ivashkiv is focused on determining the variability in an individual’s response to therapy and injury. He said that while two people can have the same procedure, their outcomes can be different. "A big effort is underway to understand this so we can improve our outcomes and prevent complications."
Read the full article at leadersmag.com. This article also appeared in the July, August, September 2017 print edition.